The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Primak A.L.

Lomonosov Moscow State University

Skryabina M.N.

Lomonosov Moscow State University

Dzhauari S.S.

Lomonosov Moscow State University

Tkachuk V.A.

Lomonosov Moscow State University

Karagyaur M.N.

Lomonosov Moscow State University

The secretome of mesenchymal stromal cells as a new hope in the treatment of acute brain tissue injuries

Authors:

Primak A.L., Skryabina M.N., Dzhauari S.S., Tkachuk V.A., Karagyaur M.N.

More about the authors

Read: 2239 times


To cite this article:

Primak AL, Skryabina MN, Dzhauari SS, Tkachuk VA, Karagyaur MN. The secretome of mesenchymal stromal cells as a new hope in the treatment of acute brain tissue injuries. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(3‑2):83‑91. (In Russ.)
https://doi.org/10.17116/jnevro202412403283

Recommended articles:
Clinical and gene­tic asso­ciations in patients with non-cardioembolic ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):12-19
Biomarkers of athe­rothrombotic and cardioembolic subtypes of acute ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):20-26
Clinical and tomo­graphic comparisons in patients with apha­sia in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):27-33
Neuroimaging predictors of hemo­rrhagic transformation of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):34-38
Neurocytoprotection adva­nces in repe­rfusion therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):75-88
Central nervous system invo­lvement in systemic lupus erythematosus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):124-129

References:

  1. Stroke, Cerebrovascular accident. World Health Organization. Accessed July 17, 2023. https://www.emro.who.int/health-topics/stroke-cerebrovascular-accident/index.html
  2. Klochihina OA, Shprakh VV, Stakhovskaya LV, Polunina EA. An analysis of the long-term stroke morbidity and mortality in the regions of the Russian Federation included in the Federal patient assistance reorganization program. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2020;120(12-2):37-41. (In Russ.). https://doi.org/10.17116/jnevro202012012237
  3. Byvaltsev VA, Kalinin AA, Belykh EG, et al. Cherepno-mozgovaya travma. Uchebnoe posobie. Irk.: FGBOU VO IGMU of the Ministry of Health of Russia; 2018. (In Russ.).
  4. Kuriakose D, Xiao Z. Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. International Journal of Molecular Sciences. 2020;21(20):7609. https://doi.org/10.3390/ijms21207609
  5. Ng S, Lee A. Traumatic Brain Injuries: Pathophysiology and Potential Therapeutic Targets. Frontiers in Cellular Neuroscience. 2019;13:528.  https://doi.org/10.3389/fncel.2019.00528
  6. Hoffman O, Weber R. Pathophysiology and treatment of bacterial meningitis. Therapeutic Advances in Neurological Disorders. 2009;2(6):1-7.  https://doi.org/10.1177/1756285609337975
  7. Surtees R, Leonard J. Acute metabolic encephalopathy: a review of causes, mechanisms and treatment. Journal of Inherited Metabolic Disease. 1989;12:42-54.  https://doi.org/10.1007/BF01799285
  8. Clinical recommendations. Ischemic stroke and transient ischemic mic attack in adults. 2022. (In Russ.). Link active as of 07/17/23.  https://cr.minzdrav.gov.ru/recomend/171_2
  9. Clinical recommendations. Hemorrhagic stroke. 2022. (In Russ.). Link activna on 07/17/23.  https://cr.minzdrav.gov.ru/recomend/523_2
  10. Anthony S, Cabantan D, Monsour M, et al. Neuroinflammation, Stem Cells, and Stroke. Stroke. 2022;53(5):1460-1472. https://doi.org/10.1161/STROKEAHA.121.036948
  11. Cox CS Jr. Cellular therapy for traumatic neurological injury. Pediatric Research. 2018;83(1-2):325-332.  https://doi.org/10.1038/pr.2017.253
  12. Sagaradze G, Basalova N, Efimenko A, et al. Mesenchymal Stromal Cells as Critical Contributors to Tissue Regeneration. Frontiers in Cell and Developmental Biology. 2020;8:576176. https://doi.org/10.3389/fcell.2020.576176
  13. Wijeratne T, Gillard Crewther S, et al. COVID-19 Pathophysiology Predicts That Ischemic Stroke Occurrence Is an Expectation, Not an Exception-A Systematic Review. Frontiers in Neurology. 2021;11:607221. https://doi.org/10.3389/fneur.2020.607221
  14. Saloheimo P, Juvela S, Riutta A, et al. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage. Thrombosis Research. 2005;115(5):367-373.  https://doi.org/10.1016/j.thromres.2004.08.026
  15. Yang Y, Rosenberg G. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke. 2011;42(11):3323-3328. https://doi.org/10.1161/STROKEAHA.110.608257
  16. Latysheva VY, Olizarovich MV, Kurman VI, et al. Neotlozhnye sostoyaniya v nevrologii i nejrohirurgii: uchebno metodicheskoe posobie dlya dlya prakticheskih zanyatij studentov 6 kursa lechebnogo fakul’teta medvuzov. Gomel: GomGMU; 2011. (In Russ.).
  17. Crowley M, Tajiri N. Exogenous stem cells pioneer a biobridge to the advantage of host brain cells following stroke: New insights for clinical applications. Brain Circulation. 2017;3(3):130-134.  https://doi.org/10.4103/bc.bc_17_17
  18. Bernardo-Castro S, Sousa J, Brás A, et al. Pathophysiology of Blood-Brain Barrier Permeability Throughout the Different Stages of Ischemic Stroke and Its Implication on Hemorrhagic Transformation and Recovery. Frontiers in Neurology. 2020;11:594672. https://doi.org/10.3389/fneur.2020.594672
  19. Gorbacheva LR, Pomytkin IA, Surin AM, et al. Astrocytes and their role in the pathology of the central nervous system. Rossijskii Pediatricheskii Zhurnal. 2018;21(1):46-53. (In Russ.). https://doi.org/10.18821/1560-9561-2018-21-1-46-53
  20. Fang X, Ding S, Du X, et al. Ferroptosis-A Novel Mechanism With Multifaceted Actions on Stroke. Frontiers in Neurology. 2022;13:881809. https://doi.org/10.3389/fneur.2022.881809
  21. Maida C, Norrito R, Daidone M, et al. Neuroinflammatory Mechanisms in Ischemic Stroke: Focus on Cardioembolic Stroke, Background, and Therapeutic Approaches. International Journal of Molecular Sciences. 2020;21(18):6454. https://doi.org/10.3390/ijms21186454
  22. Winkler E, Minter D, Yue J, et al. Cerebral Edema in Traumatic Brain Injury: Pathophysiology and Prospective Therapeutic Targets. Neurosurgery Clinics. 2016;27(4):473-488.  https://doi.org/10.1016/j.nec.2016.05.008
  23. Muzio L, Viotti A, Martino G. Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy. Frontiers in Neuroscience. 2021;15:742065. https://doi.org/10.3389/fnins.2021.742065
  24. Sorby-Adams A, Marcoionni A, Dempsey E, et al. The Role of Neurogenic Inflammation in Blood-Brain Barrier Disruption and Development of Cerebral Oedema Following Acute Central Nervous System (CNS) Injury. International Journal of Molecular Sciences. 2017;18(8):1788. https://doi.org/10.3390/ijms18081788
  25. Sifat A, Vaidya B, Abbruscato T. Blood-Brain Barrier Protection as a Therapeutic Strategy for Acute Ischemic Stroke. The AAPS Journal. 2017;19(4):957-972.  https://doi.org/10.1208/s12248-017-0091-7
  26. Lok J, Leung W, Murphy S, et al. Intracranial hemorrhage: mechanisms of secondary brain injury. Acta Neurochirurgica, Supplement. 2011;111:63-69.  https://doi.org/10.1007/978-3-7091-0693-8_11
  27. Huang L, Wu Z, Zhuge Q, et al. Glial scar formation occurs in the human brain after ischemic stroke. International Journal of Medical Sciences. 2014;11(4):344-348.  https://doi.org/10.7150/ijms.8140
  28. Yao Y, Zhang Y, Liao X, et al. Potential Therapies for Cerebral Edema After Ischemic Stroke: A Mini Review. Frontiers in Aging Neuroscience. 2021;12:618819. https://doi.org/10.3389/fnagi.2020.618819
  29. Li J, Zhang Q, Wang W, et al. Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential. Journal of Neurology. 2021;268(11):4095-4107. https://doi.org/10.1007/s00415-020-10138-5
  30. Baharoglu M, Cordonnier C, Al-Shahi Salman R, et al; PATCH Investigators. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet. 2016;387(10038):2605-2613. https://doi.org/10.1016/S0140-6736(16)30392-0
  31. Davis S, Donnan G. 4.5 hours: the new time window for tissue plasminogen activator in stroke. Stroke. 2009;40(6):2266-2267. https://doi.org/10.1161/STROKEAHA.108.544171
  32. Molina C, Montaner J, Abilleira S, et al. Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke. Stroke. 2001;32(5):1079-1084. https://doi.org/10.1161/01.str.32.5.1079
  33. Cantinieaux D, Quertainmont R, Blacher S, et al. Conditioned medium from bone marrow-derived mesenchymal stem cells improves recovery after spinal cord injury in rats: an original strategy to avoid cell transplantation. PLoS One. 2013;8(8):e69515. https://doi.org/10.1371/journal.pone.0069515
  34. Cordonnier C, Demchuk A, Ziai W, et al. Intracerebral haemorrhage: current approaches to acute management. Lancet. 2018;392(10154):1257-1268. https://doi.org/10.1016/S0140-6736(18)31878-6
  35. Gulyaeva N. Biochemical Mechanisms and Translational Relevance of Hippocampal Vulnerability to Distant Focal Brain Injury: The Price of Stress Response. Biochemistry (Moscow). 2019;84(11):1306-1328. https://doi.org/10.1134/S0006297919110087
  36. Bolshakov A, Tret’yakova L, Kvichansky A, et al. Glucocorticoids: Dr. Jekyll and Mr. Hyde of Hippocampal Neuroinflammation. Biochemistry (Moscow). 2021;86(2):156-167.  https://doi.org/10.1134/S0006297921020048
  37. Ghozy S, Reda A, Varney J, et al. Neuroprotection in Acute Ischemic Stroke: A Battle Against the Biology of Nature. Frontiers in Neurology. 2022;13:870141. https://doi.org/10.3389/fneur.2022.870141
  38. Zoerle T, Carbonara M, Zanier E, et al. Rethinking Neuroprotection in Severe Traumatic Brain Injury: Toward Bedside Neuroprotection. Frontiers in Neurology. 2017;8:354.  https://doi.org/10.3389/fneur.2017.00354
  39. Putilina MV. The use of neuropeptides of animal origin in the treatment of neurological diseases. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2023;123(9):37-42. (In Russ.). https://doi.org/10.17116/jnevro202312309137
  40. Shavlovskaya OA. Clinical efficacy of neuropeptides in cerebrovascular pathology. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2016;116(8):88-93. (In Russ.). https://doi.org/10.17116/jnevro20161168188-93
  41. Karagyaur M, Dzhauari S, Basalova N, et al. MSC Secretome as a Promising Tool for Neuroprotection and Neuroregeneration in a Model of Intracerebral Hemorrhage. Pharmaceutics. 2021;13(12):2031. https://doi.org/10.3390/pharmaceutics13122031
  42. Denner J. Porcine Endogenous Retroviruses and Xenotransplantation, 2021. Viruses. 2021;13(11):2156. https://doi.org/10.3390/v13112156
  43. Yperzeele L, Van Hooff R, De Smedt A, et al. Prehospital stroke care: limitations of current interventions and focus on new developments. Cerebrovascular Diseases. 2014;38(1):1-9.  https://doi.org/10.1159/000363617
  44. Mayer S, Brun N, Begtrup K, et al; FAST Trial Investigators. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. The New England Journal of Medicine. 2008;358(20):2127-2137. https://doi.org/10.1056/NEJMoa0707534
  45. Mendelow A, Gregson B, Rowan E, et al; STICH II Investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet. 2013;382(9890):397-408.  https://doi.org/10.1016/S0140-6736(13)60986-1
  46. Heistad D, Faraci F. Gene therapy for cerebral vascular disease. Stroke. 1996;27(9):1688-1693. https://doi.org/10.1161/01.str.27.9.1688
  47. Chrostek M, Fellows E, Crane A, et al. Efficacy of stem cell-based therapies for stroke. Brain Research. 2019;1722:146362. https://doi.org/10.1016/j.brainres.2019.146362
  48. Bonilla C, Zurita M. Cell-Based Therapies for Traumatic Brain Injury: Therapeutic Treatments and Clinical Trials. Biomedicines. 2021;9(6):669.  https://doi.org/10.3390/biomedicines9060669
  49. Kalinina YA, Gilerovich EG, Korzhevsky DE. Astrocytes and their participation in the mechanisms of therapeutic action of MSC in ischemic brain injury. Genes & Cells. 2019;14(1):33-40. (In Russ.). https://doi.org/10.23868/201903004
  50. Andres R, Horie N, Slikker H, et al. Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain. 2011;134(Pt 6):1777-1789. https://doi.org/10.1093/brain/awr094
  51. Kondziolka D, Steinberg G, Wechsler L, et al. Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. Journal of Neurosurgery. 2005;103(1):38-45.  https://doi.org/10.3171/jns.2005.103.1.0038
  52. Lee R, Pulin A, Seo M, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009;5(1):54-63.  https://doi.org/10.1016/j.stem.2009.05.003
  53. George P, Oh B, Dewi R, et al. Engineered stem cell mimics to enhance stroke recovery. Biomaterials. 2018;178:63-72.  https://doi.org/10.1016/j.biomaterials.2018.06.010
  54. Borlongan C, Hadman M, Sanberg C, et al. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke. 2004;35(10):2385-2389. https://doi.org/10.1161/01.STR.0000141680.49960.d7
  55. High K, Roncarolo M. Gene Therapy. The New England Journal of Medicine. 2019;381(5):455-464.  https://doi.org/10.1056/NEJMra1706910
  56. Ghaderi A, Abtahi S. Mesenchymal Stem Cells: Miraculous Healers or Dormant Killers? Stem Cell Reviews and Reports. 2018;14(5):722-733.  https://doi.org/10.1007/s12015-018-9824-y
  57. Zhang S, Lachance B, Moiz B, et al. Optimizing Stem Cell Therapy after Ischemic Brain Injury. Journal of Stroke. 2020;22(3):286-305.  https://doi.org/10.5853/jos.2019.03048
  58. Gutiérrez-Fernández M, Rodríguez-Frutos B, Alvarez-Grech J, et al. Functional recovery after hematic administration of allogenic mesenchymal stem cells in acute ischemic stroke in rats. Neuroscience. 2011;175:394-405.  https://doi.org/10.1016/j.neuroscience.2010.11.054
  59. Matthay M, Calfee C, Zhuo H, et al. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. The Lancet Respiratory Medicine. 2019;7(2):154-162.  https://doi.org/10.1016/S2213-2600(18)30418-1
  60. Lalu M, Montroy J, Dowlatshahi D, et al. From the Lab to Patients: a Systematic Review and Meta-Analysis of Mesenchymal Stem Cell Therapy for Stroke. Translational Stroke Research. 2020;11(3):345-364.  https://doi.org/10.1007/s12975-019-00736-5
  61. Chen L, Tredget E, Wu P, et al. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One. 2008;3(4):e1886. https://doi.org/10.1371/journal.pone.0001886
  62. Onda T, Honmou O, Harada K, et al. Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. Journal of Cerebral Blood Flow & Metabolism. 2008;28(2):329-340.  https://doi.org/10.1038/sj.jcbfm.9600527
  63. Xin H, Li Y, Liu Z, et al. MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells. 2013;31(12):2737-2746. https://doi.org/10.1002/stem.1409
  64. Chen B, Gao X, Yang C, et al. Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats. Brain Research. 2009;1284:1-11.  https://doi.org/10.1016/j.brainres.2009.05.100
  65. Sakata H, Niizuma K, Wakai T, et al. Neural stem cells genetically modified to overexpress Cu/Zn-superoxide dismutase enhance amelioration of ischemic stroke in mice. Stroke. 2012;43(9):2423-2429. https://doi.org/10.1161/STROKEAHA.112.656900
  66. Andrzejewska A, Dabrowska S, Lukomska B, et al. Mesenchymal Stem Cells for Neurological Disorders. Advanced Science. 2021;8(7):2002944. https://doi.org/10.1002/advs.202002944
  67. Mu J, Bakreen A, Juntunen M, et al. Combined Adipose Tissue-Derived Mesenchymal Stem Cell Therapy and Rehabilitation in Experimental Stroke. Frontiers in Neurology. 2019;10:235.  https://doi.org/10.3389/fneur.2019.00235
  68. Zhang Q, Chen Z, Zhao Y, et al. Bone Marrow Stromal Cells Combined With Sodium Ferulate and n-Butylidenephthalide Promote the Effect of Therapeutic Angiogenesis via Advancing Astrocyte-Derived Trophic Factors After Ischemic Stroke. Cell Transplantation. 2017;26(2):229-242.  https://doi.org/10.3727/096368916X693536
  69. Kurtz A. Mesenchymal stem cell delivery routes and fate. International Journal of Stem Cells. 2008;1(1):1-7.  https://doi.org/10.15283/ijsc.2008.1.1.1
  70. Sun H, Bénardais K, Stanslowsky N, et al. Therapeutic potential of mesenchymal stromal cells and MSC conditioned medium in Amyotrophic Lateral Sclerosis (ALS)--in vitro evidence from primary motor neuron cultures, NSC-34 cells, astrocytes and microglia. PLoS One. 2013;8(9):e72926. https://doi.org/10.1371/journal.pone.0072926
  71. Han H, Hu J, Yan Q, et al. Bone marrow-derived mesenchymal stem cells rescue injured H9c2 cells via transferring intact mitochondria through tunneling nanotubes in an in vitro simulated ischemia/reperfusion model. Molecular Medicine Reports. 2016;13(2):1517-1524. https://doi.org/10.3892/mmr.2015.4726
  72. Namioka A, Namioka T, Sasaki M, et al. Intravenous infusion of mesenchymal stem cells for protection against brainstem infarction in a persistent basilar artery occlusion model in the adult rat. Journal of Neurosurgery. 2018;1:1-9.  https://doi.org/10.3171/2018.4.JNS173121
  73. Li W, Shi L, Hu B, et al. Mesenchymal Stem Cell-Based Therapy for Stroke: Current Understanding and Challenges. Frontiers in Cellular Neuroscience. 2021;15:628940. https://doi.org/10.3389/fncel.2021.628940
  74. Zhang J, Li Y, Chen J, et al. Expression of insulin-like growth factor 1 and receptor in ischemic rats treated with human marrow stromal cells. Brain Research. 2004;1030(1):19-27.  https://doi.org/10.1016/j.brainres.2004.09.061
  75. Horita Y, Honmou O, Harada K, et al. Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. Journal of Neuroscience Research. 2006;84(7):1495-1504. https://doi.org/10.1002/jnr.21056
  76. Pischiutta F, Caruso E, Lugo A, et al. Systematic review and meta-analysis of preclinical studies testing mesenchymal stromal cells for traumatic brain injury. NPJ Regenerative Medicine. 2021;6(1):71.  https://doi.org/10.1038/s41536-021-00182-8
  77. Shanko YuG, Kulchitsky VA, Smeyanovich AF, et al. Method of treatment stroke using autologous mesenchymal stem cells adipose tissue. Minsk. 2018.
  78. Ho I, Lam P. Signaling molecules and pathways involved in MSC tumor tropism. Histology and Histopathology. 2013;28(11):1427-1438. https://doi.org/10.14670/HH-28.1427
  79. Kalinina N, Kharlampieva D, Loguinova M, et al. Characterization of secretomes provides evidence for adipose-derived mesenchymal stromal cells subtypes. Stem Cell Research & Therapy. 2015;6:221.  https://doi.org/10.1186/s13287-015-0209-8
  80. Lopatina T, Kalinina N, Karagyaur M, et al. Adipose-derived stem cells stimulate regeneration of peripheral nerves: BDNF secreted by these cells promotes nerve healing and axon growth de novo. PLoS One. 2011;6(3):e17899. https://doi.org/10.1371/journal.pone.0017899
  81. Cunningham C, Wong R, Barrington J, et al. Systemic conditioned medium treatment from interleukin-1 primed mesenchymal stem cells promotes recovery after stroke. Stem Cell Research & Therapy. 2020;11(1):32.  https://doi.org/10.1186/s13287-020-1560-y
  82. Shevela EYa, Sakhno LV, Kafanova MYu, et al. Method of obtaining conditioned media with regenerative potential for intranasal introduction in treatment of diseases of central nervous system. Patent RUS №2637407 01.06.2016. Byul. №34. (In Russ.). https://patentimages.storage.googleapis.com/0f/97/e5/143cbff816b8c7/RU2637407C1.pdf
  83. Ichim T, Patel A. Inducing and accelerating post-stroke recovery by administration of amniotic fluid derived stem cells. US patent 20180071342A1. September 12, 2017.
  84. Seyda A, Gosiewska A. Regeneration and repair of neural tissue following injury. European patent 2379089B1. December 19, 2009.
  85. Tkachuk VA, Akopyan ZhA, Efimenko AYu, et al. Method of obtaining means for stimulating regeneration based on secretion products multipotent human mesenchymal stromal cells. Patent RF for invention No. 2620167 dated December 21, 2015. Bull. No. 15. (In Russ.).
  86. Romanov YuA, Proshkin AYu, Proshkin SD, et al. Cell-free therapeutic agents for regenerative medicine and methods for preparing them. Patent RUS №2742034 04.10.18. Byul. №4. (In Russ.). https://patentimages.storage.googleapis.com/62/09/79/6f3a9dde371307/RU2742034C2.pdf
  87. Hasan A, Deeb G, Rahal R, et al. Mesenchymal Stem Cells in the Treatment of Traumatic Brain Injury. Frontiers in Neurology. 2017;8:28.  https://doi.org/10.3389/fneur.2017.00028
  88. Dzhauari S, Basalova N, Primak A, et al. The Secretome of Mesenchymal Stromal Cells in Treating Intracerebral Hemorrhage: The First Step to Bedside. Pharmaceutics. 2023;15(6):1608. https://doi.org/10.3390/pharmaceutics15061608
  89. Cunningham C, Redondo-Castro E, Allan S. The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke. Journal of Cerebral Blood Flow & Metabolism. 2018;38(8):1276-1292. https://doi.org/10.1177/0271678X18776802
  90. Pischiutta F, Caruso E, Cavaleiro H, et al. Mesenchymal stromal cell secretome for traumatic brain injury: Focus on immunomodulatory action. Experimental Neurology. 2022;357:114199. https://doi.org/10.1016/j.expneurol.2022.114199
  91. Efimenko A, Kalinina N, Rubina K, et al. Secretome of Multipotent Mesenchymal Stromal Cells as a Promising Treatment and for Rehabilitation of Patients with the Novel Coronaviral Infection. Herald of the Russian Academy of Sciences. 2021;91(2):170-175.  https://doi.org/10.1134/S101933162102012X
  92. Tayler H, Miners J, Güzel Ö, et al. Mediators of cerebral hypoperfusion and blood-brain barrier leakiness in Alzheimer’s disease, vascular dementia and mixed dementia. Brain Pathology. 2021;31(4):e12935. https://doi.org/10.1111/bpa.12935
  93. Efimenko A, Starostina E, Kalinina N, et al. Angiogenic properties of aged adipose derived mesenchymal stem cells after hypoxic conditioning. Journal of Translational Medicine. 2011;9:10.  https://doi.org/10.1186/1479-5876-9-10
  94. Petrenko Y, Vackova I, Kekulova K, et al. Comparative Analysis of Multipotent Mesenchymal Stromal Cells derived from Different Sources, with a Focus on Neuroregenerative Potential. Scientific Reports. 2020;10(1):4290. https://doi.org/10.1038/s41598-020-61167-z
  95. Cui L, Golubczyk D, Tolppanen A, et al. Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy? Annals of Neurology. 2019;86(1):5-16.  https://doi.org/10.1002/ana.25493
  96. Alegre M, Bartman C, Chong A. Microbes and allogeneic transplantation. Transplantation. 2014;97(1):5-11.  https://doi.org/10.1097/TP.0b013e3182a2037f
  97. Xiong Y, Song J, Huang X, et al. Exosomes Derived From Mesenchymal Stem Cells: Novel Effects in the Treatment of Ischemic Stroke. Frontiers in Neuroscience. 2022;16:899887. https://doi.org/10.3389/fnins.2022.899887
  98. Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct. #NCT05008588. ClinicalTrials.gov. Accessed July 17, 2023. https://www.clinicaltrials.gov/study/NCT05008588?term=NCT05008588&rank=1

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.